March 4, 2022

Featured

DBV Technologies S.A. (DBVT) Stock Plunged 21.71% Pre-Market, Here’s Why

DBV Technologies S.A. (DBVT) stock plummeted 21.71% in the pre-market trading session at the price of $1.37 after reporting its earnings report for the full year 2021. DBVT is producing Viaskin, proprietary technology with extended applications in immunotherapy. Viaskin operates on EPIT to develop biologically

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.